Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long‐term responseMiriam Marangon, Francesco Zaja, Cristina Santoro et al.|European Journal Of Haematology|2016Cited by 90
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III TrialGian Maria Zaccaria, Marco Ladetto, Simone Ferrero et al.|Cancers|2021Cited by 13